These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Concise review: Human cell engineering: cellular reprogramming and genome editing. Mali P; Cheng L Stem Cells; 2012 Jan; 30(1):75-81. PubMed ID: 21905170 [TBL] [Abstract][Full Text] [Related]
5. Stem cells in drug discovery, tissue engineering, and regenerative medicine: emerging opportunities and challenges. Nirmalanandhan VS; Sittampalam GS J Biomol Screen; 2009 Aug; 14(7):755-68. PubMed ID: 19675315 [TBL] [Abstract][Full Text] [Related]
6. Differentiation of pluripotent stem cells for regenerative medicine. Li K; Kong Y; Zhang M; Xie F; Liu P; Xu S Biochem Biophys Res Commun; 2016 Feb; 471(1):1-4. PubMed ID: 26851367 [TBL] [Abstract][Full Text] [Related]
7. Advances in regenerative medicine. Advances in Regenerative Medicine, 13 June 2008, BioPark, Hertfordshire, UK. Clarke BR Regen Med; 2008 Sep; 3(5):769-70. PubMed ID: 18729801 [No Abstract] [Full Text] [Related]
10. Pluripotent stem cells: the last 10 years. Kimbrel EA; Lanza R Regen Med; 2016 Dec; 11(8):831-847. PubMed ID: 27908220 [TBL] [Abstract][Full Text] [Related]
11. Derivation and application of pluripotent stem cells for regenerative medicine. Wang J; Zhou Q Sci China Life Sci; 2016 Jun; 59(6):576-83. PubMed ID: 27225262 [TBL] [Abstract][Full Text] [Related]
12. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine. Gomes KM; Costa IC; Santos JF; Dourado PM; Forni MF; Ferreira JC Rev Assoc Med Bras (1992); 2017 Feb; 63(2):180-189. PubMed ID: 28355380 [TBL] [Abstract][Full Text] [Related]
13. Sources of stem cells for regenerative medicine. Hipp J; Atala A Stem Cell Rev; 2008; 4(1):3-11. PubMed ID: 18286392 [TBL] [Abstract][Full Text] [Related]
14. Regenerative medicine and organ transplantation: past, present, and future. Orlando G; Wood KJ; Stratta RJ; Yoo JJ; Atala A; Soker S Transplantation; 2011 Jun; 91(12):1310-7. PubMed ID: 21505379 [TBL] [Abstract][Full Text] [Related]
16. Clinically relevant aspects of stem cell technologies: current state of play. Stuart MJ; Pattavilakom A ANZ J Surg; 2015 Sep; 85(9):615-9. PubMed ID: 25267417 [TBL] [Abstract][Full Text] [Related]
17. Chemical control of stem cell fate and developmental potential. Lyssiotis CA; Lairson LL; Boitano AE; Wurdak H; Zhu S; Schultz PG Angew Chem Int Ed Engl; 2011 Jan; 50(1):200-42. PubMed ID: 21184400 [TBL] [Abstract][Full Text] [Related]
18. Pluripotent Stem Cells for Retinal Tissue Engineering: Current Status and Future Prospects. Singh R; Cuzzani O; Binette F; Sternberg H; West MD; Nasonkin IO Stem Cell Rev Rep; 2018 Aug; 14(4):463-483. PubMed ID: 29675776 [TBL] [Abstract][Full Text] [Related]
19. The standpoint of stem cell research. Romano G Drug News Perspect; 2008 Sep; 21(7):408-12. PubMed ID: 19259554 [TBL] [Abstract][Full Text] [Related]
20. The 'sweet' spot of cellular pluripotency: protein glycosylation in human pluripotent stem cells and its applications in regenerative medicine. Wang YC; Lin V; Loring JF; Peterson SE Expert Opin Biol Ther; 2015 May; 15(5):679-87. PubMed ID: 25736263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]